Taipei Exchange - Delayed Quote TWD
Intech Biopharm Corporation (6461.TWO)
18.00
+0.05
+(0.28%)
As of 10:10:39 AM GMT+8. Market Open.
Key Executives
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Wei-Shiu Wu | General Manager | 2.91M | -- | -- |
| Mr. Yan-Qin Zhao | Senior Division Head and Chief R&D Officer | 2.49M | -- | -- |
| Ms. Chien-Yiu Yang | Finance Division Head | 1.42M | -- | -- |
| Hugues Hung | Chief Financial Officer | -- | -- | -- |
Intech Biopharm Corporation
No. 36, Ruiguang Road
3rd Floor Lane 358 Neihu District
Taipei, 114
Taiwan
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 90
Description
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Corporate Governance
Intech Biopharm Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
4168.TWO GlycoNex Incorporation
18.00
0.00%
4130.TWO Genovate Biotechnology Co., Ltd.
21.00
+0.24%
6662.TWO BioLASCO Taiwan Co., Ltd.
33.50
+3.08%
6492.TWO Senhwa Biosciences, Inc.
33.15
+0.15%
3118.TWO Level Biotechnology Inc.
32.90
-4.91%
6733.TWO BioGend Therapeutics Co., Ltd.
28.45
+0.35%
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
29.45
+0.17%
3205.TWO Sagittarius Life Science Corp
23.90
+2.36%
4726.TWO Mycenax Biotech Inc.
32.70
+2.51%
4167.TWO Savior Lifetec Corporation
20.20
-1.22%